Americas & Europe Tendinitis Treatment Market-Forecast till 2023
Tendinitis is an inflammatory disease of the tendons causing pain and tenderness at the injured site. The prevalence of tendinitis is found to be increasing among athletes as well as general population. Diagnosis of tendinitis is done through physical examination, imaging tests such as X-ray, Magnetic Resonance Imaging (MRI), and ultrasound. MRI is the most common diagnostic test used for diagnosis of tendinitis. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) are commonly used pharmacological treatment for tendinitis. Better results are also obtained through rest therapy, occupational therapy, and physical therapy.
There is numerous treatment option for tendinitis are available in the market, but all come varied side effects. Thus, it emphasizes a need for new technologies and therapies. Reducing duration of treatment and speeding the process of healing along with cost-effective treatments are driving the tendinitis treatment market. Hence, new approaches to tendinitis treatment may further determine the growth of the market.
New technologies and therapies paving ways for the market growth
The urge of innovative products and new technology is the essence of medicine, which can be achieved through research and development activities. For instance, Tenex Health TX is the company that has introduced new technology named “TX Technology” for treating tendon injuries. The technology uses ultra-sound imaging and patented TX MicroTip technology that reduces pain and swelling.
High-intensity laser therapy is emerging as a promising treatment for tendinitis. The therapy is regarded to be fast and safe by various research studies. The therapy uses laser emission for tissue penetration resulting in high thermal gradient as well as photochemical effects. This improves tissue repair as well as increases lymphatic drainage in the injured areas.
Additionally, Ayurveda is another effective treatment used for the treatment of tendinitis. Ayurvedic medications such as ashwagandha, Boswellia, and vitex nigundo can use used for the treatment of tendinitis as they help to reduce pain and regain strength. These medications have a similar action as that of NSAIDs as well as minimal or no side effects. Also, there is a number of patented ayurvedic products manufactured by ayurvedic pharmacies. For Instance, “Rumalaya liniment” is ayurvedic formulation patented by Himalaya.
Era of sports medicine
Sports medicine is gaining grounds in developing economies across the globe. It is a branch of medicine dealing with prevention, treatment, and management of sports injuries. Increasing demand for diagnosis of sports injuries and availability of skilled healthcare professionals are accelerating the growth of the market. Muscle, bones, and tendon injuries such as muscle strain anterior cruciate ligament (ACL) sprains, ACL tears, ankle sprain, shin splints, and muscle strains are the most common types of sports injuries. Additionally, tendinitis is a result of continuous strain or stress on the tendon, whose prevalence is found to be increasing among athletes. Therefore, management of tendon injuries in a need of an hour. Management of tendinitis signifies the need for new treatment methods and therapies. Severe injuries thus can be treated. Prominent organizations such as American College of Sports Medicine (ACSM), and American Orthopedic Society for Sports Medicine (AOSSM) are now focusing on the management of sports injuries.
Sports injuries are one of the common injuries that are normally encountered in the accident and emergency (A&E) departments of the hospitals, and the number is increasing to the emergency department due to sports injuries. As per the Hospital Episode Statistics data, in 2015, a total number of muscle and tendon injuries were 280,808 in the European countries.
Factors accelerating the growth of the market
Increasing prevalence of sports injuries and chronic diabetes and arthritis are a major driver for the growth of the market in the American and European countries.
According to the Center for Disease Control and Prevention (CDC), from 2013 to 2015, an estimated 54.4 million U.S. adults annually diagnosed with rheumatoid arthritis, gout, lupus, or fibromyalgia. It also stated that the risk of arthritis increases with the age. Additionally, the disease is more common in women than men.
Diabetes is one of the chronic diseases creating a socio-economic impact on the lives of the people. According to the American Diabetes Association, in 2015, approximately 30.3 million Americans i.e. 9.4% of the American population had diabetes. Many research studies state that there is a significant association between diabetes and tendon pain. Achilles tendinitis is the most commonly linked to diabetes. In case of diabetic patients, high blood sugar leads to abnormal thickening of the tendon.
Factor deteriorating the market growth
Side effects of treatment such NSAIDs deteriorate the growth of the market. According to the report published by American Academy of Clinical Toxicology, nearly 70 million prescriptions for NSAIDs are prescribed in the U.S. each year. Use of NSAIDs leads to the ulcers, irritation of the stomach lining, and kidney problems.
Strategic Approaches of the Key Players
Pfizer, Teva Pharmaceuticals, GlaxoSmithKline, Merck & Co. Inc., Bayer, Abbott, and AstraZeneca are key players in the tendinitis treatment market. The key players in the market are engaged in strategic approaches such as mergers and acquisitions, partnerships, and new product development. For instance, in April 2016, the company acquired “Actavis Generics” to strengthen its position in the global and U.S. generics markets.
Therefore, tendinitis treatment market is governed by the development of new technologies and treatment methods for tendinitis, and various business strategies incorporated by key players.